Japanese food inhibits development of liver fibrosis: Study Isra Zaman27 April 2023 9:30 AM ISTThere is a scoring system named "the 12-component modified Japanese Diet Index (mJDI12)," which focuses on the intake of the Japanese diet pattern. It...
Increased coffee consumption may reduce severity of NAFLD in type 2 diabetes patients Dr. Kamal Kant Kohli14 Jan 2023 11:15 AM ISTResearchers at University of Coimbra have found in a new study that Increased coffee consumption may reduce severity of NAFLD in type 2 diabetes...
Fibrosis-4 stage of liver fibrosis linked with CV events in ACS patients regardless of diabetes status Medha Baranwal12 Dec 2022 10:30 AM ISTChina: Liver fibrosis staged by the Fibrosis-4 (FIB-4) index corresponds to an increased risk of myocardial infarction, MACCE, and mortality in acute...
Even mild liver disease may hamper heart health, finds Cedars-Sinai study Isra Zaman10 Dec 2022 9:15 AM ISTEarlier this year, the American Heart Association (AHA) released a statement that nonalcoholic fatty liver disease-an increasingly common liver...
First-degree relatives of patients with NAFLD at risk of developing liver disease Dr. Kamal Kant Kohli3 Nov 2022 8:30 PM ISTNonalcoholic fatty liver disease (NAFLD) afflicts approximately one-fourth of the general population worldwide and it has emerged as an important...
Link between NAFLD and heart failure risk Isra Zaman27 July 2022 9:30 AM ISTThe build-up of fat in the liver, known as non-alcoholic fatty liver disease, or NAFLD for short, is linked to a heightened risk of heart failure...
Hydronidone- a novel antifibrotic add-on therapy for liver fibrosis in chronic hepatitis B Dr. Hiral patel18 July 2022 8:15 PM ISTChina: A new Investigational drug hydronidone, when used with entecavir showed clinically significant efficiency and safety in patients with chronic...
Pfizer gets USFDA Fast Track Designation for Ervogastat plus Clesacostat to treat NASH Ruchika Sharma28 May 2022 11:57 AM ISTDiacylglycerol O-acyltransferase 2 (DGAT2) and acetyl-CoA carboxylase (ACC) are two key enzymes that regulate lipid metabolism. Inhibitors of ACC and...
Kisspeptin: A new drug for treatment of NAFLD Dr. Kamal Kant Kohli9 April 2022 10:00 AM ISTGlobally, NAFLD is the most common form of chronic liver disease that affects children and adults and is linked to the rise in obesity and Type 2...
Diabetes increases risk of liver fibrosis in obese NAFLD patients: Study Dr. Shravani Dali4 Nov 2021 9:45 AM ISTDiabetes Mellitus (DM) is a significant risk factor of liver fibrosis in obese and overweight patients, according to a study published in the...
High BMI Carries Great Risk of Liver Fibrosis In Pediatric Patients: Study dr anusha7 Sept 2021 10:00 AM ISTNon-alcoholic fatty liver disease is the common etiology for chronic liver disease in children in developed world with a prevalence of 3-10% in...
Statins lower risk of advanced liver fibrosis in diabetes patients: Study Medha Baranwal20 March 2021 8:20 AM ISTItaly: Statin use lowers the risk of cirrhosis and advanced liver fibrosis in type 2 diabetes (T2D) patients, finds a recent study in the journal...
